Trials / Unknown
UnknownNCT03123575
Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy
Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy in The Region Of Madrid: A Population-Based, Cross-Sectional Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Hospital General Universitario Gregorio Marañon · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This will be a cross-sectional population-based study carried out in the region of Madrid (6,468,322 inhabitants according to current census) to quantify the number of Co-meds in HIV-infected individuals on ART in the region of Madrid, categorized by age and gender, and to compare the number of Co-meds between the ART-treated population and HIV-uninfected population in the region of Madrid, categorized by age and gender.
Detailed description
This will be a cross-sectional population-based study carried out in the region of Madrid (6,468,322 inhabitants according to current census) to quantify the number of Co-meds in HIV-infected individuals on ART in the region of Madrid, categorized by age and gender, and to compare the number of Co-meds between the ART-treated population and HIV-uninfected population in the region of Madrid, categorized by age and gender.
Conditions
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2017-04-21
- Last updated
- 2017-06-09
Source: ClinicalTrials.gov record NCT03123575. Inclusion in this directory is not an endorsement.